Efficacy of a weight loss program prior to robot assisted radical prostatectomy in overweight and obese men with prostate cancer.


Journal

Surgical oncology
ISSN: 1879-3320
Titre abrégé: Surg Oncol
Pays: Netherlands
ID NLM: 9208188

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 27 03 2020
revised: 03 07 2020
accepted: 02 08 2020
pubmed: 6 9 2020
medline: 12 10 2021
entrez: 5 9 2020
Statut: ppublish

Résumé

Obesity in prostate cancer patients is associated with poor prostate-cancer specific outcomes. Exercise and nutrition can reduce fat mass; however, few studies have explored this as a combined pre-surgical intervention in clinical practice. This study examined the efficacy of a weight loss program for altering body composition in prostate cancer patients prior to robot assisted radical prostatectomy (RARP). A retrospective analysis of 43 overweight and obese prostate cancer patients, aged 47-80 years, who completed a very low-calorie diet (~3000-4000 kJ) combined with moderate-intensity exercise (90 min/day) prior to RARP. Whole body and regional fat mass (FM) and lean mass (LM) were assessed by dual-energy x-ray absorptiometry pre- and post-program. Body weight, waist circumference, and blood pressure were assessed weekly, with surgery-related adverse effects recorded at time of surgery and follow-up appointments. With a median of 29 days (IQR: 24-35days) on the program, patients significantly (p < 0.001) reduced weight (-7.3 ± 2.9 kg), FM (-5.0 ± 2.6 kg), percent body fat (-3.1 ± 2.5%), trunk FM (-3.4 ± 1.8 kg), LM (-2.4 ± 1.8 kg), and appendicular LM (-1.2 ± 1.0 kg). Lower weight, FM, percent FM, trunk FM, and visceral FM were associated with less surgery-related adverse effects (r Undertaking a combined low-calorie diet and exercise program for weight loss in preparation for RARP resulted in substantial reductions in FM, with improvements in blood pressure, that may benefit surgical outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Obesity in prostate cancer patients is associated with poor prostate-cancer specific outcomes. Exercise and nutrition can reduce fat mass; however, few studies have explored this as a combined pre-surgical intervention in clinical practice.
PURPOSE OBJECTIVE
This study examined the efficacy of a weight loss program for altering body composition in prostate cancer patients prior to robot assisted radical prostatectomy (RARP).
METHODS METHODS
A retrospective analysis of 43 overweight and obese prostate cancer patients, aged 47-80 years, who completed a very low-calorie diet (~3000-4000 kJ) combined with moderate-intensity exercise (90 min/day) prior to RARP. Whole body and regional fat mass (FM) and lean mass (LM) were assessed by dual-energy x-ray absorptiometry pre- and post-program. Body weight, waist circumference, and blood pressure were assessed weekly, with surgery-related adverse effects recorded at time of surgery and follow-up appointments.
RESULTS RESULTS
With a median of 29 days (IQR: 24-35days) on the program, patients significantly (p < 0.001) reduced weight (-7.3 ± 2.9 kg), FM (-5.0 ± 2.6 kg), percent body fat (-3.1 ± 2.5%), trunk FM (-3.4 ± 1.8 kg), LM (-2.4 ± 1.8 kg), and appendicular LM (-1.2 ± 1.0 kg). Lower weight, FM, percent FM, trunk FM, and visceral FM were associated with less surgery-related adverse effects (r
CONCLUSION CONCLUSIONS
Undertaking a combined low-calorie diet and exercise program for weight loss in preparation for RARP resulted in substantial reductions in FM, with improvements in blood pressure, that may benefit surgical outcomes.

Identifiants

pubmed: 32889251
pii: S0960-7404(20)30349-2
doi: 10.1016/j.suronc.2020.08.006
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

182-188

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Auteurs

Rebekah L Wilson (RL)

Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia. Electronic address: r.newton@ecu.edu.au.

Tom Shannon (T)

The Prostate Clinic, Perth, WA, Australia; Hollywood Private Hospital, Perth, WA, Australia.

Emily Calton (E)

School of Public Health, Curtin University, Perth, WA, Australia.

Daniel A Galvão (DA)

Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.

Dennis R Taaffe (DR)

Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia; School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Australia.

Nicolas H Hart (NH)

Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia; Institute for Health Research, University of Notre Dame Australia, Perth, WA, Australia.

Philippa Lyons-Wall (P)

School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.

Robert U Newton (RU)

Exercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia; School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia; School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH